Dr. Mridul Agrawal
"Dr. Mridul Agrawal is a physician-scientist, healthcare entrepreneur, and transatlantic business leader driving the future of cancer care through human-centered health technology innovation. As Managing Director and Co-Founder of iuvando Health, Dr. Agrawal is pioneering new pathways for cancer patients to benefit from cutting edge and life saving treatments in clinical trials. Under his leadership, iuvando has emerged as the premier patient portal for clinical trial access in oncology. The company has received numerous accolades, including the German Startup Award, the EY Public Value Award for societal impact, and the EIT Health Headstart Award for European healthcare innovation. Beyond entrepreneurship, Dr. Agrawal is a recognized thought leader shaping the global health innovation agenda. He is a Fellow of the Sciana Health Leaders Network at Salzburg Global and a member of Atlantik-Brücke, where he actively promotes transatlantic dialogue on healthcare policy and innovation. He also advises organizations such as the German-American Business Council, the German Accelerator and Heidelberg University among many others, and regularly engages with top-level policymakers and C-level leaders across industry, healthcare and academia. His perspectives on healthcare innovation, technology, and entrepreneurship are featured in leading international media outlets. A recipient of the prestigious German Academic Scholarship Foundation Award, Dr. Agrawal studied medicine and health economics at Heidelberg University, complemented by academic training at Johns Hopkins University and the University of Zurich. He pursued clinical training in hematology and medical oncology in Germany, followed by a postdoctoral fellowship at the Dana-Farber Cancer Institute and Harvard Medical School in Boston, supported by the German Research Foundation."